The product is used to delay the progression of children’s myopia aged 6-12 with spherical lenses of -1.00D to -4.00D (astigmatism≤1.50D and anisometropia≤1.50D)
Promotes tear secretion in patients with dry eyes. For patients with reduced tear secretion caused by ocular inflammation associated with keratoconjunctivitis sicca.
For keratohelcosis and corneal injury due to various causes, corneal bum caused by acid or alkali, bullous keratitis, neuroparalytic keratitis, as well as corneal and conjunctival degeneration.
For keratohelcosis and corneal injury due to various causes, corneal bum caused by acid or alkali, bullous keratitis, neuroparalytic keratitis, as well as corneal and conjunctival degeneration.
Meticulous Attention to Details Ensures Quality Products
The Qipan Mountain Factory of Sinqi Ophthalmic Medications was put into production in 2014. It was designed in accordance with US FDA CGMP and EU GMP standards and is equipped with workshops and facilities that are up to China’s GMP standards. As of 2020, the company had invested about RMB 700 million in total in the factory. It has production lines for extractives, single-dose eye drops, multi-dose eye drops, ophthalmic gel, ophthalmic solution and inner packaging materials for ophthalmic medications that are up to China’s GMP standards.
▲Calf blood extraction line▲
▲Single dose eye drops production line▲
▲Multi-dose eye drops production line▲
▲Eye gel production line▲
▲Eye solution production line▲